Search Results - "Juan, Santibañez F."

Refine Results
  1. 1

    TGF-β/TGF-β receptor system and its role in physiological and pathological conditions by Santibañez, Juan F, Quintanilla, Miguel, Bernabeu, Carmelo

    Published in Clinical science (1979) (01-09-2011)
    “…The TGF-β (transforming growth factor-β) system signals via protein kinase receptors and Smad mediators to regulate a plethora of biological processes,…”
    Get more information
    Journal Article
  2. 2

    Oxidative Stress in Disease and Aging: Mechanisms and Therapies 2016 by Cabello-Verrugio, Claudio, Simon, Felipe, Trollet, Capucine, Santibañez, Juan F.

    Published in Oxidative medicine and cellular longevity (01-01-2017)
    “…Oxidative stress (OS) is an imbalance between the formation of reactive oxygen species (ROS) and antioxidant defense mechanisms. This phenomenon increases with…”
    Get full text
    Journal Article
  3. 3

    Interleukin-17 and Its Implication in the Regulation of Differentiation and Function of Hematopoietic and Mesenchymal Stem Cells by Bugarski, Diana, Santibanez, Juan F., Krstić, Aleksandra, Mojsilović, Slavko

    Published in Mediators of Inflammation (01-01-2015)
    “…Adult stem cells have a great potential applicability in regenerative medicine and cell-based therapies. However, there are still many unresolved issues…”
    Get full text
    Journal Article
  4. 4

    Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2 by Kocić, Jelena, Santibañez, Juan F., Krstić, Aleksandra, Mojsilović, Slavko, Đorđević, Ivana Okić, Trivanović, Drenka, Ilić, Vesna, Bugarski, Diana

    Published in Biochimica et biophysica acta (01-04-2012)
    “…The present study evaluated the role of interleukin (IL) 17 in multilineage commitment of C2C12 myoblastic cells and investigated associated signaling…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase by Kocić, Jelena, Santibañez, Juan F., Krstić, Aleksandra, Mojsilović, Slavko, Ilić, Vesna, Bugarski, Diana

    “…► IL-17 inhibits urokinase type plasminogen activator (uPA) expression in C2C12 myoblasts. ► The inhibition of uPA expression was concomitant with IL-17…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional Interactions in Tumor Stroma-Infiltrating Myeloid Cells by Kocić, Jelena, Santibanez, Juan F.

    Published in TheScientificWorld (01-01-2014)
    “…Transforming growth factor-beta (TGF-β) is a pleiotropic factor with several different roles in health and disease. In tumorigenesis, it may act as a…”
    Get full text
    Journal Article
  10. 10

    In vitro effects of IL-17 on angiogenic properties of endothelial cells in relation to oxygen levels by Krstić, Jelena, Jauković, Aleksandra, Mojsilović, Slavko, Đorđević, Ivana Okić, Trivanović, Drenka, Ilić, Vesna, Santibañez, Juan F., Bugarski, Diana

    Published in Cell biology international (01-11-2013)
    “…The aim of this study has been to elucidate how different oxygen levels impact the effects of Interleukin‐17 (IL‐17) on angiogenic properties of endothelial…”
    Get full text
    Journal Article
  11. 11

    JNK mediates TGF-β1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes by Santibañez, Juan F.

    Published in FEBS letters (02-10-2006)
    “…In this study we analyzed the role of the c-Jun N-terminal kinases (JNK) pathway in the TGF-β1 stimulation of urokinase-type plasminogen activator (uPA),…”
    Get full text
    Journal Article
  12. 12

    Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression by Santibanez, Juan F., Mojsilović, Slavko, Trivanović, Drenka, Kocić, Jelena

    Published in Oxidative medicine and cellular longevity (01-01-2015)
    “…Transforming growth factor-beta (TGF-β) and oxidative stress/Reactive Oxygen Species (ROS) both have pivotal roles in health and disease. In this review we are…”
    Get full text
    Journal Article
  13. 13

    ROS-NFκΒ mediates TGF-β1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion by Tobar, Nicolas, Villar, Victor, Santibanez, Juan F

    Published in Molecular and cellular biochemistry (01-07-2010)
    “…TGF-β1 has been postulated as a pro-oncogenic factor in the late step of the tumoral progression. In transformed cells, TGF-β1 enhances the capacity to degrade…”
    Get full text
    Journal Article
  14. 14

    Ha-Ras sensitizes transformed mouse skin cells to Anisomycin-induced apoptosis by Santibañez, Juan F., Hurtado, Claudia

    Published in FEBS letters (21-11-2005)
    “…Efforts have been made to develop a chemoprevention that selectively triggers apoptosis in malignant cancer cells. Here, we demonstrated that a mutated Ha-Ras…”
    Get full text
    Journal Article
  15. 15

    Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin by Smith, Patricio C., Santibañez, Juan F., Morales, Juan P., Martinez, Jorge

    Published in Journal of periodontal research (01-12-2004)
    “…Background:  Regulation of the extracellular matrix turnover is a crucial process in wound healing and the progress of periodontal disease. It has been…”
    Get full text
    Journal Article
  16. 16

    Urokinase Type Plasminogen Activator and the Molecular Mechanisms of its Regulation in Cancer by Santibanez, Juan F

    Published in Protein and peptide letters (01-01-2017)
    “…Urokinase type plasminogen activator (uPA) is a 53-kDa serine protease initially synthesized as a catalytically inactive single chain polypeptide. Inactive-uPA…”
    Get more information
    Journal Article
  17. 17

    Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention by Ruzic, Dusan, Djoković, Nemanja, Srdić-Rajić, Tatjana, Echeverria, Cesar, Nikolic, Katarina, Santibanez, Juan F

    Published in Pharmaceutics (16-01-2022)
    “…The dysregulation of gene expression is a critical event involved in all steps of tumorigenesis. Aberrant histone and non-histone acetylation modifications of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Author Correction: Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells by Srdic-Rajic, Tatjana, Santibañez, Juan F., Kanjer, Ksenija, Tisma-Miletic, Nevena, Cavic, Milena, Galun, Daniel, Jevric, Marko, Kardum, Nevena, Konic-Ristic, Aleksandra, Zoranovic, Tamara

    Published in Scientific reports (26-10-2018)
    “…A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper…”
    Get full text
    Journal Article
  20. 20

    Current and Future Cancer Chemoprevention Strategies by Santibanez, Juan F, Villar, Victor H, Echeverria, Cesar

    Published in Pharmaceutics (19-05-2023)
    “…Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 and ranking as the second-leading cause of death in economically…”
    Get full text
    Journal Article